Hyperglycemia in patients with focal cerebral ischemia after intravenous thrombolysis: influence on clinical outcome and infarct size.
about
Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attackPeroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attackPeroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attackAcute Stroke: Current Evidence-based Recommendations for Prehospital CareAggressive glucose control for acute ischemic stroke patients by insulin infusion.Association of fibrinogen level with early neurological deterioration among acute ischemic stroke patients with diabetes.Lack of association between hyperglycaemia at arrival and clinical outcomes in acute stroke patients treated with tissue plasminogen activator.Intracerebroventricular Kainic Acid-Induced Damage Affects Blood Glucose Level in d-glucose-fed Mouse ModelHyperglycemia alters mitochondrial fission and fusion proteins in mice subjected to cerebral ischemia and reperfusion.Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis.Early changes in physiological variables after stroke.Hyperglycemia and diabetes have different impacts on outcome of ischemic and hemorrhagic stroke.A review of perioperative glucose control in the neurosurgical populationSugar and stroke: cerebrovascular disease and blood glucose control.Hyperglycemia: a prothrombotic factor?Hyperglycemia in aneurysmal subarachnoid hemorrhage: a potentially modifiable risk factor for poor outcome.Hyperglycaemia monitoring and management in stroke care: policy vs. practice.The influence of stroke risk factors and comorbidities on assessment of stroke therapies in humans and animals.Admission hyperglycaemia and cerebral perfusion deficits in acute ischaemic stroke.Bed rest or mobilization after rt-PA? A case-crossover study of factors influencing clinical decision making in stroke services.Perioperative glucose control in neurosurgical patients.Diabetes mellitus, acute hyperglycemia, and ischemic stroke.[Secondary prophylaxis of stroke from a neurological perspective].Transient lack of glucose but not O2 is involved in ischemic postconditioning-induced neuroprotection.Preventing glycaemic excursions in diabetic patients requiring percutaneous endoscopic gastrostomy (PEG) feeding after a stroke.Blood glucose in acute stroke.Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack.Ischemic vagus nuclei lesions and hyperglycemia: a study in 26 patients with lateral medullary infarction and matched controls.Uric acid improves glucose-driven oxidative stress in human ischemic stroke.Acute ischemic stroke patients with diabetes should not be excluded from intravenous thrombolysis.Development of brain infarct volume as assessed by magnetic resonance imaging (MRI): Follow-up of diffusion-weighted MRI lesions
P2860
Q24186319-4782BC02-7013-4FEB-86B2-6B436449DD20Q24200885-4DCAFA83-0738-4F3B-A329-599EE7D06119Q24201174-866223D5-745E-46E1-B54C-1B4A110FDEB9Q28069451-48D8FC5B-89AD-4F55-9230-37BD41F2DEA3Q33590729-9F42F88C-27EB-4959-B918-405299E8CBE7Q33709160-B2789F22-DB21-4366-ADCC-9443FD5D299FQ34051719-A6B0E50F-4BC5-428E-B110-0AC5265F170DQ35187244-BE0086D9-41A2-4B6F-B716-5CA093CD9D6FQ36795702-19E1C50D-4B52-446F-AC75-9EAF2B2D0E16Q37139530-8694B4DE-79B3-4450-A7DA-FE101CF3161EQ37409110-78B0DDA2-6F57-4558-9D0E-150466AA24F5Q37549354-30566C5F-57CB-4CDC-A99A-03BFF466E28BQ37689888-302E0895-886D-448F-AF3C-0ABFF2EBBBD5Q37759025-B9A164A0-C102-4F09-971E-EFFDEA65A346Q37759238-E66915A0-32C0-4C52-99F6-D1031293C406Q37772395-0079CA19-2939-4354-9542-657EFF788EC2Q38003201-A3265686-5A34-4537-AF76-3590AF73B896Q38019965-7DEFD7F0-277E-4C7A-A88A-A855DF1FE83FQ39463753-23B669FD-ED9C-4144-8D77-FDD9ACC7D427Q39685305-2E514B1F-1C87-4886-9FF0-97390A10DEB8Q41560664-ACCCC265-4780-4649-B7F2-CB2D01FF3B6BQ42147201-79AB4837-75BE-4F39-8ABA-27607A64B278Q43833530-A123F693-026F-40E7-B599-0E5C25E74836Q43841074-0183FA26-31C5-40E1-A1A5-7F0C75A9B9CAQ44369240-258D73A2-9EA1-4529-9EF6-558586F68536Q46094875-568276D0-CD21-4B6D-B6B8-AC4C32E92D79Q47380989-3582EDE1-75EB-4BC8-82FC-6407AB2B78C1Q48262254-B219214A-F475-4EDE-9D0A-B1A3F359F226Q48357007-657B59BF-68BC-4173-8B9C-98186C2590EBQ48671195-DF391A81-C4AE-48EA-AD34-35FBD18ECF1DQ57514835-2E8A31BA-DA8F-4499-B230-822E32AFD188
P2860
Hyperglycemia in patients with focal cerebral ischemia after intravenous thrombolysis: influence on clinical outcome and infarct size.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Hyperglycemia in patients with ...... ical outcome and infarct size.
@en
Hyperglycemia in patients with ...... ical outcome and infarct size.
@nl
type
label
Hyperglycemia in patients with ...... ical outcome and infarct size.
@en
Hyperglycemia in patients with ...... ical outcome and infarct size.
@nl
prefLabel
Hyperglycemia in patients with ...... ical outcome and infarct size.
@en
Hyperglycemia in patients with ...... ical outcome and infarct size.
@nl
P2093
P921
P356
P1476
Hyperglycemia in patients with ...... ical outcome and infarct size.
@en
P2093
Lücking CH
Schulte-Mönting J
Schumacher M
P356
10.1159/000047756
P577
2002-01-01T00:00:00Z